Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

17th International Nanomedicine & Drug Delivery Symposium NanoDDS

22 - 24 September 2019, Cambridge, United States


Introduction
The 17th International Nanomedicine and Drug Delivery Symposium (NanoDDS'19) will be held on the MIT campus September 22-24, 2019. We anticipate accommodating >400 participants from around the world. This symposium will particularly focus on translation medicine, and will be featuring speakers from both biotech industry and academia.

 
Speakers
  • Robert S. Langer MIT, United States
  • Andrew D. Schiermeier Intellia Therapeutics, United States
  • Niren Murthy University of California at Berkeley, United States
  • Sangeeta Bhatia MIT, United States
  • Matthias P Nahrendorf Massachusetts General Hospital, United States
  • James (Jay) Bradner Novartis Institute for BioMedical Research, United States
  • Konstantin Konstantinov Cokiak BioSciences, United States
  • Noubar Afeyan Flagship Pioneering, United States
  • Vincent M. Rotello U Mass Amherst, United States
  • Michael S. Strano MIT, United States
  • Stephane Bancel Moderna, United States
  • Zhengyi Chen Harvard Medical School, United States
  • Jordan Greene Johns Hopkins University, United States
  • Christopher Cheng Casebia Therapeutics, United States
  • Charlie Albright Editas Medicine, United States
  • Darrell Irvine MIT, United States
  • Paula T. Hammond MIT, United States
  • William Shih Harvard Medical School, United States
  • Ronald C. Renaud Translate, United States
  • Tony De Fougerolles Evox Therapeutics, United States
  • David L. Kaplan Tufts University, United States
  • Justin Hanes Johns Hopkins University, United States
  • Vasant Jadhav Alnylam Pharmaceuticals, United States
  • Maria José Alonso University of Santiago de Compostela, Spain
  • Tony Ho CRISPR Therapeutics, United States
  • Mansoor M. Amiji Northeastern University, United States
  • Gregory Verdine Fog Pharma, United States

Venue
Massachusetts Institute of Technology

MIT Building W16: Kresge Auditorium, Massachusetts Institute of Technology, 48 MASSACHUSETTS AVE, Cambridge, MA 02139, United States

Organised by

Daniel Anderson

Associate Professor, Chemical Engineering and Institute for Medical Engineering and Science, Massachusetts Institute of Technology

Qiaobing Xu

Associate Professor, Department of Biomedical Engineering, Tufts University
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*